Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +16.10%
#2 Fake World Assets Fake World Assets +11.89%
#3 OriginTrail OriginTrail +8.84%
#4 B3 (Base) B3 (Base) +7.77%
#5 Pons Pons +5.38%
#6 Storj Storj +5.13%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +4.30%
#8 Audiera Audiera +3.81%
#9 Strategy PP Variable xStock Strategy PP Variable xStock +3.03%
#10 Geodnet Geodnet +2.92%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
설정
언어
한국어
통화
USD
테마
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
주식 순위 #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
주가
$2.22
마지막 동기화: 2026-08-21
시가총액
$117.70M
변동 (1일)
2.69%
변동 (1년)
17.26%
국가
SE
거래 SynAct Pharma AB (SYNACT)

카테고리

Healthcare
SynAct Pharma AB (SYNACT)의 주가 이력
최고 종가: $2.19 (2026-08-01 기준)

최저 종가: $0.56 (2016-07-01 기준)
SynAct Pharma AB의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -7.35%
2025 144.78%
2024 17.64%
2023 -89.62%
2022 -48.77%
2021 236.22%
2020 376.82%
2019 16.49%
2018 -27.27%
2017 82.38%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH